Jennifer Buell, Chief Executive Officer at MiNK Therapeutics, sold INKT on Oct 12, 2026
Data as of Oct 16
▼ SELL$73.3K6,938 shares at $10.56Jennifer Buell Chief Executive OfficerINKT MiNK Therapeutics, Inc.
- Traded
- Oct 12, 2026
- Disclosed
- Oct 14, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
INKT since disclosure
−9.1%
after the sale
Similar stocks (SPY) since disclosure
−0.8%
S&P 500 (SPY)
Change in closing price from Oct 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.